FONTANA, FABRIZIO
FONTANA, FABRIZIO
Dipartimento di Scienze Farmacologiche e Biomolecolari
The PI3K/Akt Pathway and Glucose Metabolism: A Dangerous Liaison in Cancer
2024 F. Fontana, G. Giannitti, S. Marchesi, P. Limonta
Differentiation States of Phenotypic Transition of Melanoma Cells Are Revealed by 3D Cell Cultures
2024 F. Fontana, M. Sommariva, M. Anselmi, F. Bianchi, P. Limonta, N. Gagliano
Adipocytes reprogram prostate cancer stem cell machinery
2023 F. Fontana, M. Anselmi, P. Limonta
PGC1-α-driven mitochondrial biogenesis contributes to a cancer stem cell phenotype in melanoma
2023 F. Fontana, C. Macchi, M. Anselmi, A.S. Rizzuto, M. Ruscica, P. Limonta
Unraveling the Peculiar Features of Mitochondrial Metabolism and Dynamics in Prostate Cancer
2023 F. Fontana, M. Anselmi, P. Limonta
Melanoma Stem Cells Educate Neutrophils to Support Cancer Progression
2022 M. Anselmi, F. Fontana, M. Marzagalli, N. Gagliano, M. Sommariva, P. Limonta
Exploiting the Metabolic Consequences of PTEN Loss and Akt/Hexokinase 2 Hyperactivation in Prostate Cancer: A New Role for δ-Tocotrienol
2022 F. Fontana, M. Anselmi, P. Limonta
Molecular Mechanisms of Cancer Drug Resistance: Emerging Biomarkers and Promising Targets to Overcome Tumor Progression
2022 F. Fontana, M. Anselmi, P. Limonta
Adipocyte-Derived Extracellular Vesicles Promote Prostate Cancer Cell Aggressiveness by Enabling Multiple Phenotypic and Metabolic Changes
2022 F. Fontana, M. Anselmi, E. Carollo, P. Sartori, P. Procacci, D. Carter, P. Limonta
Molecular mechanisms and genetic alterations in prostate cancer: From diagnosis to targeted therapy
2022 F. Fontana, M. Anselmi, P. Limonta
A multi-organ-on-chip to recapitulate the infiltration and the cytotoxic activity of circulating NK cells in 3D matrix-based tumor model
2022 M. Marzagalli, G. Pelizzoni, A. Fedi, C. Vitale, F. Fontana, S. Bruno, A. Poggi, A. Dondero, M. Aiello, R. Castriconi, C. Bottino, S. Scaglione
Ca2+ overload- and ROS-associated mitochondrial dysfunction contributes to δ-tocotrienol-mediated paraptosis in melanoma cells
2021 M. Raimondi, F. Fontana, M. Marzagalli, M. Audano, G. Beretta, P. Procacci, P. Sartori, N. Mitro, P. Limonta
Cancer Stem Cells—Key Players in Tumor Relapse
2021 M. Marzagalli, F. Fontana, M. Raimondi, P. Limonta
Extracellular Vesicles: Emerging Modulators of Cancer Drug Resistance
2021 F. Fontana, E. Carollo, G.E. Melling, D.R.F. Carter
Gene expression profile reveals that APOA-I levels modulate inflammation and lysosomal activity in murine advances atherosclerosis
2021 M. Busnelli, S. Manzini, A. Colombo, F. Fontana, R. Oleari, F. Potì, S. Castiglioni, S. Bellosta, G. Chiesa
The multifaceted roles of mitochondria at the crossroads of cell life and death in cancer
2021 F. Fontana, P. Limonta
In vitro 3D cultures to model the tumor microenvironment
2021 F. Fontana, M. Marzagalli, M. Sommariva, N. Gagliano, P. Limonta
δ‐Tocotrienol sensitizes and re‐sensitizes ovarian cancer cells to cisplatin via induction of G1 phase cell cycle arrest and ROS/MAPK‐mediated apoptosis
2021 F. Fontana, M. Marzagalli, M. Raimondi, V. Zuco, N. Zaffaroni, P. Limonta
Dissecting the Hormonal Signaling Landscape in Castration-Resistant Prostate Cancer
2021 F. Fontana, P. Limonta
Aortic gene expression profiles show how ApoA-I levels modulate inflammation, lysosomal activity, and sphingolipid metabolism in murine atherosclerosis
2021 M. Busnelli, S. Manzini, M. Chiara, A. Colombo, F. Fontana, R. Oleari, F. Poti, D. Horner, S. Bellosta, G. Chiesa